
For over 20 years, we have been creating distinctive investments for our private and family office clients and institutional clients, mainly in Europe and the United States. We are committed to providing them with a long-term return on their investment that meets their expectations.
A value-added approach alongside partners who have a solid track record
Conviction-based management with a controlled risk/return ratio
Investing in HealthTech which brings together stocks of companies in the medical sector that use new technologies to offer sustainable solutions for prevention and care, uniting health and innovation.
Pergam is pursuing its development in value add real estate and has created an investment vehicle in the leading office market in Europe, Germany.
Investing in listed companies of the fast-growing SAAS sector, which allows companies to improve efficiency, profitability and productivity.
This site is an information site with the objective of presenting Pergam’s portfolio management activity as well as the main characteristics of its UCIs and services. It does not constitute a canvassing activity, an offer of securities or a public offering.
Access to the products and services presented on the site may be subject to restrictions with regard to certain persons, and in particular non-professional clients in accordance with the provisions of Article L.533 of the French Monetary and Financial Code and Directive 2004/39/EC on markets in financial instruments, or certain countries, and in particular with regard to investors in the United States who are subject to specific legislation. In addition, the products and services presented on this site may only be purchased in jurisdictions where they are authorised to be marketed and promoted.
If you are interested in any of the services or UCIs presented on this site, we advise you to ensure that you are legally entitled to subscribe to them. The information on the site is provided for information purposes only and does not release the user from undertaking additional and personalised analysis.
This site, and all the information presented on it, are governed by French law. Certain laws prohibit or restrict access to this site. We therefore ask you to ensure that you are legally entitled to connect to it in the country from which the connection is made.
To return to the home page of this site, click ‘Continue’.